Literature DB >> 3024207

Portal hemodynamics in patients with hepatocellular carcinoma.

F Moriyasu, N Ban, O Nishida, T Nakamura, Y Soh, K Miura, M Sakai, T Miyake, H Uchino.   

Abstract

The protal blood flow was assessed in 46 patients with hepatocellular carcinoma, 81 with cirrhosis, and 110 control subjects using an ultrasonic B-mode pulsed Doppler duplex system. The cross-sectional area of the portal vein was increased, and the velocity of portal blood flow was decreased in hepatocellular carcinoma and cirrhosis, whereas the blood flow volume was not significantly different. A significant decrease in portal blood flow was found in hepatocellular carcinoma only when at least three of the four major branches of the portal vein were occluded. The change in portal hemodynamics before and after transcatheter arterial embolization (TAE) was investigated. Immediately after TAE, neither portal venous pressure nor portal blood flow showed any constant trend. The portal blood flow reached a peak 1 week after TAE and then returned to its former value after 3-4 weeks, while all cases with poor prognoses showed a drop in portal blood flow after TAE.

Entities:  

Mesh:

Year:  1986        PMID: 3024207     DOI: 10.1148/radiology.161.3.3024207

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Measurement of normal portal venous blood flow by Doppler ultrasound.

Authors:  H S Brown; M Halliwell; M Qamar; A E Read; J M Evans; P N Wells
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

2.  Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT).

Authors:  Y Tsushima; Y Unno; J Koizumi; S Kusano
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

3.  Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma.

Authors:  S Bianco; C Merkel; S Savastano; S Bellon; M Chiesura-Corona; M Bolognesi; D Miotto; E Enzo; G Feltrin; A Gatta
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

4.  Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver.

Authors:  Joseph P Erinjeri; Ajita Deodhar; Raymond H Thornton; Peter J Allen; George I Getrajdman; Karen T Brown; Constantinos T Sofocleous; Diane L Reidy
Journal:  Cardiovasc Intervent Radiol       Date:  2009-09-16       Impact factor: 2.740

5.  Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma.

Authors:  Bernhard Scheiner; Gregor Ulbrich; Mattias Mandorfer; Thomas Reiberger; Christian Müller; Fredrik Waneck; Michael Trauner; Claus Kölblinger; Arnulf Ferlitsch; Wolfgang Sieghart; Markus Peck-Radosavljevic; Matthias Pinter
Journal:  United European Gastroenterol J       Date:  2019-03-21       Impact factor: 4.623

6.  Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure.

Authors:  Constantine Frangakis; Jae Ho Sohn; Ahmet Bas; Julius Chapiro; Ruediger E Schernthaner; MingDe Lin; James P Hamilton; Timothy M Pawlik; Kelvin Hong; Rafael Duran
Journal:  Front Oncol       Date:  2021-11-05       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.